Kura Oncology, Inc. - Common Stock (KURA)

Kura Oncology is a biopharmaceutical company focused on the development of innovative medicines for the treatment of cancer

The company is committed to advancing its proprietary drug candidates that target specific genetic and epigenetic drivers of cancer progression, utilizing their expertise in precision medicine to address unmet medical needs. Through rigorous research and clinical trials, Kura aims to bring transformative therapies to patients suffering from various types of cancer, including rare and hard-to-treat forms. Their goal is to improve outcomes and quality of life for patients by providing targeted treatments that leverage the unique characteristics of their tumors.